Skip to main content

Clinical Trials

Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.

What's new

heart failure diabetes drug

A new study will investigate whether SGLT-2 inhibitor Farxiga can delay the progression of heart failure in people with and without type 2 diabetes Continue Reading »

Type 1 Diabetes Sleep Pilot Study; Tidepool; Evidation Health; clinical trial; Dexcom CGM

Contribute data to a new study on how overnight blood sugars affect sleep, activity, and mental state; four-week “virtual” trial recruiting people with type 1 on Dexcom CGM and a compatible pump Continue Reading »

Zynquista clinical trial

A study recruiting 10,000 people will look at whether Zynquista (sotagliflozin) has effects beyond glucose-lowering and weight loss Continue Reading »

Tandem control-IQ

Recruiting now! This major study will support FDA submission of Tandem’s t:slim X2 with Control-IQ and Dexcom G6 in people with type 1 ages 14 and up; includes automatic boluses for high blood sugars Continue Reading »

Trulicity high dose study

A new study is investigating whether higher doses of injectable GLP-1 agonist Trulicity (dulaglutide) are more effective; it is recruiting 1,800 participants with type 2 diabetes Continue Reading »

heart health diabetes

Two new studies will investigate whether SGLT-2 inhibitor Jardiance impacts heart failure in people with and without diabetes. Jardiance is already approved to lower A1C and reduce the risk of heart-related death Continue Reading »

All of Us Research Program

Learn more about the All of Us Research Program, a massive national effort to collect individual health data to support precision medicine research Continue Reading »

diabetes heart health study

Two new studies will investigate whether SGLT-2 inhibitor Farxiga impacts heart failure in people with type 2 diabetes and prediabetes Continue Reading »

Pages